Recalls from Apotex Corp.

• Apotex Paroxetine Extended-Release Tablets (opens in a new tab)
  Moderate risk, FDA, Sep 29, 2026, Drug dissolving problem
• Apotex Paxil CR, Paroxetine, Extended-Release Tablets (opens in a new tab)
  Moderate risk, FDA, Aug 27, 2026, Drug dissolving problem
• Apotex Desmopressin Nasal Spray (opens in a new tab)
  Moderate risk, FDA, Apr 16, 2026, Packaging defect
• Apotex Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution (opens in a new tab)
  Moderate risk, FDA, Mar 16, 2026, Sterility problem

Data: Recall Canary (opens in a new tab)